Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/9/26 16:26 | 2/6/26 | TWST | Health | BioPrd | Biological Products, (No Diag | Johannessen Jan | CA | D | 2 | S | -280 | 30.28 | 0 | -9 | 18 | D | ||||||||||||||||
2/5/26 16:05 | 2/3/26 | TWST | Health | BioPrd | Biological Products, (No Diag | Finn Patrick John | CA | O | P,COO | 4 | S.d | -1,212 | 40.18 | 0 | -30 | 333 | D | |||||||||||||||
2/5/26 16:05 | 2/3/26 | TWST | Health | BioPrd | Biological Products, (No Diag | Cho Dennis | CA | O | See Rema | 4 | S | -96 | 37.06 | 0 | -3 | 145 | D | |||||||||||||||
2/5/26 16:05 | 2/3/26 | TWST | Health | BioPrd | Biological Products, (No Diag | Leproust Emily M. | CA | DO | CEO | 4 | S.d | -433 | 37.58 | 0 | -12 | 878 | D | |||||||||||||||
2/5/26 16:05 | 2/3/26 | TWST | Health | BioPrd | Biological Products, (No Diag | Werner Robert F. | CA | O | Chief Ac | 3 | S.m | -365 | 43.15 | 0 | -8 | 66 | D | |||||||||||||||
2/5/26 16:05 | 2/3/26 | TWST | Health | BioPrd | Biological Products, (No Diag | Green Paula | CA | O | SVP of H | 4 | S | -110 | 37.30 | 0 | -3 | 168 | D | |||||||||||||||
1/15/26 16:13 | 1/13/26 | TWST | Health | BioPrd | Biological Products, (No Diag | Laponis Adam | CA | O | CFO | 3 | S | -240 | 36.23 | 0 | -7 | 143 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |